Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Emphysema in People Living With HIV
NCT05382208Phase 2Active, not recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Aug 2022
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in emphysema comparing Doxycycline with Placebo (2 arms). Primary endpoint: Rate of decline of percent predicted diffusing capacity for carbon monoxide at 72 weeks. Started Aug 2022; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
emphysema
Beyond the preview
Go deeper on NCT05382208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05382208.